Terms: = Leukemia AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
50 results:
1. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations.
Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260
[TBL] [Abstract] [Full Text] [Related]
2. An In Vitro Model for Acute Myeloid leukemia Relapse Using the SORE6 Reporter.
Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
[TBL] [Abstract] [Full Text] [Related]
3. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells.
Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM) Resistance in Acute Myeloid leukemia (AML).
Song Y; Chen X; Huang R; Liu J
Curr Pharm Biotechnol; 2023; 24(5):676-685. PubMed ID: 35718982
[TBL] [Abstract] [Full Text] [Related]
5. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
Chen X; Wen F; Li Z; Li W; Zhou M; Sun X; Zhao P; Zou C; Liu T
Cancer Med; 2022 Sep; 11(18):3479-3490. PubMed ID: 35488386
[TBL] [Abstract] [Full Text] [Related]
6. Hsa-miR-625 Upregulation Promotes Apoptosis in Acute Myeloid leukemia Cell Line by Targeting Integrin-linked Kinase Pathway.
Aliabedi B; Mousavi SH; Ebrahimi M; Alizadeh S; Hedayati Asl AA; Mohammad M; Samieyan Dehkordi S
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1159-1167. PubMed ID: 35485671
[TBL] [Abstract] [Full Text] [Related]
7. 5-
Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
[TBL] [Abstract] [Full Text] [Related]
8. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
[TBL] [Abstract] [Full Text] [Related]
9. PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the oct4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma.
Liu X; Zhang Z; Kan S; Lv Z; Zhou S; Liu X; Jing P; Xu W
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982773
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
Wang H; Di X; Bi Y; Sun S; Wang T
Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
[TBL] [Abstract] [Full Text] [Related]
11. Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways.
Han JM; Kim HL; Jung HJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924032
[TBL] [Abstract] [Full Text] [Related]
12. Targeting oct3 attenuates doxorubicin-induced cardiac injury.
Huang KM; Zavorka Thomas M; Magdy T; Eisenmann ED; Uddin ME; DiGiacomo DF; Pan A; Keiser M; Otter M; Xia SH; Li Y; Jin Y; Fu Q; Gibson AA; Bonilla IM; Carnes CA; Corps KN; Coppola V; Smith SA; Addison D; Nies AT; Bundschuh R; Chen T; Lustberg MB; Wang J; Oswald S; Campbell MJ; Yan PS; Baker SD; Hu S; Burridge PW; Sparreboom A
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495337
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Survival Motor Neuron Protein on Germ Cell Development in Mouse and Human.
Chang WF; Peng M; Hsu J; Xu J; Cho HC; Hsieh-Li HM; Liu JL; Lu CH; Sung LY
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440839
[TBL] [Abstract] [Full Text] [Related]
14. Application of platelet-rich plasma (PRP) improves self-renewal of human spermatogonial stem cells in two-dimensional and three-dimensional culture systems.
Khadivi F; Koruji M; Akbari M; Jabari A; Talebi A; Ashouri Movassagh S; Panahi Boroujeni A; Feizollahi N; Nikmahzar A; Pourahmadi M; Abbasi M
Acta Histochem; 2020 Dec; 122(8):151627. PubMed ID: 33002788
[TBL] [Abstract] [Full Text] [Related]
15. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract] [Full Text] [Related]
16. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
17. Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation.
Moon HJ; Park SY; Lee SH; Kang CD; Kim SH
Oncol Res; 2019 Jul; 27(7):835-847. PubMed ID: 30982499
[TBL] [Abstract] [Full Text] [Related]
18. Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Xiang Y; Zhou X
Hematology; 2018 Dec; 23(10):721-728. PubMed ID: 29950146
[TBL] [Abstract] [Full Text] [Related]
19. Expression of embryonic stem cell markers in acute myeloid leukemia.
Picot T; Aanei CM; Fayard A; Flandrin-Gresta P; Tondeur S; Gouttenoire M; Tavernier-Tardy E; Wattel E; Guyotat D; Campos L
Tumour Biol; 2017 Jul; 39(7):1010428317716629. PubMed ID: 28718379
[TBL] [Abstract] [Full Text] [Related]
20. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line.
Karimabad MN; Mahmoodi M; Jafarzadeh A; Darehkordi A; Hajizadeh MR; Khorramdelazad H; Sayadi AR; Rahmani F; Hassanshahi G
Immunol Lett; 2017 Oct; 190():7-14. PubMed ID: 28690187
[TBL] [Abstract] [Full Text] [Related]
[Next]
